Compares two electrical stimulation methods for deep brain stimulation in Parkinson's disease
Compares two stimulation modes of brain implants in people with Parkinson's disease.
Plain-language title generated from the registry record
Registry title: Constant Current Versus Constant Voltage Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease
Key facts
- Where
- Beijing, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT06742450, who can take part
Where in China
- Xuanwu Hospital of Capital Medical UniversityBeijing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Xuanwu Hospital, Beijing
- Trial code
- NCT06742450
- Record updated
- 19 December 2024
- Original description
To compare the efficacy, programming burden, power consumption, and physicians' and patients' satisfaction between current mode and voltage mode of deep brain stimulation in each period one year after surgery.Read full original descriptionShow less
Prospective Study of Constant Current Versus Constant Voltage Deep Brain Stimulation in Patients with Parkinson's Disease
To compare the efficacy, programming burden, power consumption, and physicians' and patients' satisfaction between current mode and voltage mode of deep brain stimulation in each period one year after surgery.
Inclusion: Patients with idiopathic Parkinson's disease; Aged 18 to 75, no limited sex; After bilateral STN-DBS, yet not powered on.
Exclusion: Mental disorders or dementia; Serious health conditions, such as tumors, liver or kidney diseases, etc; Epilepsy or other seizure disorders; Pregnant, lactating women or women who are unable to take effective measures to prevent pregnancy; Patients with severely deviated electrode placement; Patients who were unable to voluntarily sign an informed consent form; Patients who did not agree to cooperate with follow-up.